flurbiprofen has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Bruin, N | 1 |
| Schneider, AK | 1 |
| Reus, P | 1 |
| Talmon, S | 1 |
| Ciesek, S | 1 |
| Bojkova, D | 1 |
| Cinatl, J | 1 |
| Lodhi, I | 1 |
| Charlesworth, B | 1 |
| Sinclair, S | 1 |
| Pennick, G | 1 |
| Laughey, WF | 1 |
| Gribbon, P | 1 |
| Kannt, A | 1 |
| Schiffmann, S | 1 |
1 other study available for flurbiprofen and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection.
Topics: Acetaminophen; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2022 |